INS and diabetes mellitus: The increased event risk in insulin-treated patients may be attributable to the generally longer history of diabetes mellitus, during which the diabetes-induced chronic vascular inflammation stimulates the progression of atherosclerosis, alters plaque composition and promotes the development of advanced lesions.